{"id":10974,"date":"2026-07-13T08:30:00","date_gmt":"2026-07-13T08:30:00","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=10974"},"modified":"2026-07-13T08:30:00","modified_gmt":"2026-07-13T08:30:00","slug":"the-direct-medical-cost-of-essential-tremor","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=10974","title":{"rendered":"The Direct Medical Cost of Essential Tremor"},"content":{"rendered":"
\n
\n

Objectives<\/h2>\n

The aim of the study was to determine the direct medical cost of illness from essential tremor (ET) from a patient perspective. \n<\/p>\n

Methods<\/h2>\n

Secondary data from the Optum\u2019s de-identified Clinformatics\u00ae Data Mart Database from 2018-2019 were used to assess medical resource utilization and costs. Propensity score matching was used to match patients aged 40+ to statistically similar controls. Generalized linear models were used to estimate average, adjusted total costs of care per year, by healthcare setting, and provider specialty.<\/p>\n

Results<\/h2>\n

The final sample included 41,200 patients with at least one ET claim and 36,871 matched patients. Overall, ET patients aged 40+ had about USD 28,217 in direct medical costs per year, which was about USD 1,601 more than matched comparisons (p < 0.001). This was driven by greater number of outpatient visits overall and with specialists. Extrapolating the estimates from our study and pairing them with published age-specific disease prevalence statistics for ET, we calculated an annual cost for direct medical care of ET patients aged 40+ to be about USD 9.4 billion.<\/p>\n

Conclusion<\/h2>\n

The estimated direct medical costs among adults aged 40+ with an ET diagnosis aggregated to the population level are nontrivial.<\/p>\n<\/div>\n<\/div>\n

\n
\n